06:15 AM EDT, 07/23/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported fiscal Q2 adjusted earnings Wednesday of $5.36 per diluted share, down from $5.37 a year earlier.

Analysts polled by FactSet expected $5.23.

Revenue for the quarter ended June 28 was $10.86 billion, compared with $10.54 billion a year earlier.

Analysts polled by FactSet expected $10.68 billion.

The company's shares were up 1.9% in recent premarket activity.